Analysis Kancera: Capital raised for phase II
Kancera’s main project KAND567 has successfully completed its phase Ib study. The next step is a…
Analysis Cantargia: targeted share issue – a sign of strength
In February 2020 Cantargia implemented a targeted new share issue of SEK 410 million, which enables the…
Analysis Adventure Box: Good potential at high risk
Adventure Box continues to grow in number of visitors on their platform. Numbers regarding active users…
Analysis Amasten: Exciting corner in SSM
Amasten profit in Q4 2019 included relative small property value gains, though the overall result…
Analysis Flowscape: International expansion
Flowscape increase its sales with a growing client base, where recurring revenues gradually will move up…
Analysis Bonesupport: Continued Growth
Bonesupport shows continued growth in North America as well as in Europe and the rest of the world. The…
Analysis Ascelia Pharma: Phase III with Mangoral
Ascelia Pharma have included the first patient in their pivotal study SPARKLE with the contrast agent…
Analysis Soltech: Strong growth but the Corona virus is a short term threat
Soltech delivers growth in both business segments but the Corona virus could inhibit the growth…
Analysis Raytelligence: Broadens sales to several sectors
Raytelligence radar sensor measures the patient´s vital parameters (breathing, pulse and movement…
Analysis Netmore: Further expanding its network
The transformation phase that the business of Netmore went through from Q2 2019 has continued…
Analysis Magnolia Bostad: Back on the targeted margins
Magnolia Bostad posted a profit in Q4 2019, although somewhat short of our forecast. The company seems to…
Analysis Kopy Goldfields: Gold price lifts project value
Gold prices have continued to rise which leads to higher project valuations. An ounce now costs more than…
